Your browser doesn't support javascript.
loading
Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder.
Suthoff, Ellison; Kosinski, Mark; Arnaud, Alix; Hodgkins, Paul; Gunduz-Bruce, Handan; Lasser, Robert; Silber, Christopher; Sankoh, Abdul J; Li, Haihong; Werneburg, Brian; Jonas, Jeffrey; Doherty, James; Kanes, Stephen J; Bonthapally, Vijayveer.
Affiliation
  • Suthoff E; Sage Therapeutics, Inc., Cambridge, MA, United States of America. Electronic address: ellison.suthoff@sagerx.com.
  • Kosinski M; Optum, Johnston, RI, United States of America.
  • Arnaud A; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Hodgkins P; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Gunduz-Bruce H; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Lasser R; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Silber C; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Sankoh AJ; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Li H; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Werneburg B; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Jonas J; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Doherty J; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Kanes SJ; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Bonthapally V; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
J Affect Disord ; 308: 19-26, 2022 07 01.
Article de En | MEDLINE | ID: mdl-35378149

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Trouble dépressif majeur Type d'étude: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limites: Adult / Humans Langue: En Journal: J Affect Disord Année: 2022 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Trouble dépressif majeur Type d'étude: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limites: Adult / Humans Langue: En Journal: J Affect Disord Année: 2022 Type de document: Article